Compare · ATTO vs LITE
ATTO vs LITE
Side-by-side comparison of Atento S.A. (ATTO) and Lumentum Holdings Inc. (LITE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ATTO and LITE operate in Telecommunications Equipment (Telecommunications), so they compete in similar markets.
- LITE is the larger of the two at $78.77B, about 243.8x ATTO ($323.0M).
- Over the past year, ATTO is down 37.3% and LITE is up 399.5% - LITE leads by 436.8 points.
- LITE has been more active in the news (20 items in the past 4 weeks vs 1 for ATTO).
- LITE has more recent analyst coverage (25 ratings vs 5 for ATTO).
- Company
- Atento S.A.
- Lumentum Holdings Inc.
- Price
- $13.74-7.10%
- $823.01-5.36%
- Market cap
- $323.0M
- $78.77B
- 1M return
- -39.36%
- -7.87%
- 1Y return
- -37.32%
- +399.52%
- Industry
- Telecommunications Equipment
- Telecommunications Equipment
- Exchange
- NYSE
- NASDAQ
- IPO
- 2014
- News (4w)
- 1
- 20
- Recent ratings
- 5
- 25
Atento S.A.
Atento S.A., together with its subsidiaries, provides customer relationship management, and business process outsourcing services and solutions in Brazil, the Americas, Europe, the Middle East, and Africa. It offers a range of front and back-end services, including sales, customer care, technical support, collections, and back office, as well as applications-processing and credit-management. The company serves clients primarily in the telecommunications, banking, and financial services sectors; and in multi-sectors, including consumer goods, services, public administration, travel, healthcare, and transportation and logistics, as well as technology and media. It provides its services and solutions through digital channels, which include SMS, email, chats, social media and apps, and others, as well as through voice. The company was formerly known as Atento Floatco S.A. Atento S.A. was founded in 1999 and is based in Luxembourg.
Lumentum Holdings Inc.
Lumentum Holdings Inc. manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company operates in two segments, Optical Communications (OpComms) and Commercial Lasers (Lasers). The OpComms segment offers components, modules, and subsystems that enable the transmission and transport of video, audio, and data over high-capacity fiber optic cables. It offers tunable transponders, transceivers, and transmitter modules; tunable lasers, receivers, and modulators; transport products, such as reconfigurable optical add/drop multiplexers, amplifiers, and optical channel monitors, as well as components, including 980nm, multi-mode, and Raman pumps; and switches, attenuators, photodetectors, gain flattening filters, isolators, wavelength-division multiplexing filters, arrayed waveguide gratings, multiplex/de-multiplexers, and integrated passive modules. This segment also provides Super Transport Blade, which integrates optical transport functions into a single-slot blade; vertical-cavity surface-emitting lasers; directly modulated and electro-absorption modulated lasers; and laser illumination sources for 3D sensing systems. It serves customers in telecommunications, data communications, and consumer and industrial markets. The Commercial Lasers segment offers diode-pumped solid-state, fiber, diode, direct-diode, and gas lasers for use in original equipment manufacturer applications. It serves customers in markets and applications, such as sheet metal processing, general manufacturing, biotechnology, graphics and imaging, remote sensing, and precision machining. Lumentum Holdings Inc. was incorporated in 2015 and is headquartered in San Jose, California.
Latest ATTO
- Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
- Attovia Therapeutics to Participate in Upcoming Investor Conferences
- Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
- RBC Capital Mkts initiated coverage on Attovia Therapeutics with a new price target
- Morgan Stanley initiated coverage on Attovia Therapeutics with a new price target
- Citigroup initiated coverage on Attovia Therapeutics with a new price target
- Leerink Partners initiated coverage on Attovia Therapeutics with a new price target
- Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq
- Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering
Latest LITE
- Lumentum, Astera Labs, and Corning to Demonstrate 1060 nm VCSEL-Based PCIe over Optics for AI Rack-Scale Connectivity at the 2026 OCP Global Summit
- SEC Form DEFA14A filed by Lumentum Holdings Inc.
- SEC Form DEF 14A filed by Lumentum Holdings Inc.
- Lumentum Announces Reporting Date for Fiscal First Quarter 2027 Financial Results
- EVP & CHIEF FINANCIAL OFFICER Ali Wajid sold $25,732,287 worth of shares (24,542 units at $1,048.50) as part of a pre-agreed trading plan, decreasing direct ownership by 25% to 75,074 units (SEC Form 4)
- SEC Form 144 filed by Lumentum Holdings Inc.
- Lumentum Announces Speaker Lineup at 2026 OCP Global Summit
- PRESIDENT, GLOBAL BUS. UNITS Wupen Yuen sold $764,365 worth of shares (807 units at $947.17) as part of a pre-agreed trading plan, decreasing direct ownership by 0.74% to 108,320 units (SEC Form 4)
- Bernstein initiated coverage on Lumentum with a new price target
- SEC Form 144 filed by Lumentum Holdings Inc.